iHuman(IH)
$1.07+0.05 (+4.90%)
IH
iHuman financials statements
$1.07
At close:+0.05 (+4.90%)
Want to see IH full AI Analyst Report?
iHuman (IH) Ratios
96 Followers
iHuman Ratios
IH's free cash flow for Q2 2026 was ¥0.00. For the 2026 fiscal year, IH's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.57 | 2.98 | 2.82 | 2.23 | 2.10 |
| Quick Ratio | 3.51 | 2.93 | 2.78 | 2.20 | 2.04 |
| Cash Ratio | 3.16 | 2.51 | 2.47 | 1.87 | 1.77 |
| Solvency Ratio | 0.28 | 0.24 | 0.39 | 0.21 | -0.06 |
| Operating Cash Flow Ratio | 0.14 | 0.13 | 0.35 | 2.30 | 0.08 |
| Short-Term Operating Cash Flow Coverage | 23.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | ¥ 925.78M | ¥ 877.02M | ¥ 889.75M | ¥ 689.84M | ¥ 522.73M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.00 | 0.01 | 0.03 |
| Debt-to-Equity Ratio | 0.01 | 0.02 | 0.00 | 0.01 | 0.06 |
| Debt-to-Capital Ratio | 0.01 | 0.02 | 0.00 | 0.01 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.37 | 1.48 | 1.51 | 1.73 | 1.81 |
| Debt Service Coverage Ratio | 47.59 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.11 | 1.42 | 0.37 | 0.85 | 3.21 |
| Net Debt to EBITDA | -10.41 | -8.92 | -7.05 | -8.50 | 17.17 |
| Profitability Margins | |||||
| Gross Profit Margin | 67.86% | 69.42% | 70.84% | 70.13% | 69.93% |
| EBIT Margin | 12.61% | 11.99% | 15.70% | 11.32% | -5.74% |
| EBITDA Margin | 13.57% | 13.47% | 16.85% | 12.42% | -5.06% |
| Operating Profit Margin | 8.27% | 7.80% | 15.70% | 11.32% | -5.74% |
| Pretax Profit Margin | 12.61% | 11.99% | 19.90% | 13.47% | -3.94% |
| Net Profit Margin | 11.82% | 10.69% | 17.77% | 11.14% | -3.92% |
| Continuous Operations Profit Margin | 11.82% | 10.69% | 17.77% | 11.14% | -3.92% |
| Net Income Per EBT | 93.73% | 89.14% | 89.30% | 82.71% | 99.61% |
| EBT Per EBIT | 152.48% | 153.80% | 126.70% | 118.99% | 68.57% |
| Return on Assets (ROA) | 6.97% | 6.94% | 12.47% | 8.24% | -3.37% |
| Return on Equity (ROE) | 9.58% | 10.26% | 18.89% | 14.27% | -6.09% |
| Return on Capital Employed (ROCE) | 6.64% | 7.40% | 16.66% | 14.45% | -8.78% |
| Return on Invested Capital (ROIC) | 6.21% | 6.57% | 14.85% | 11.86% | -8.41% |
| Return on Tangible Assets | 7.06% | 7.03% | 12.68% | 8.39% | -3.45% |
| Earnings Yield | 63.20% | 76.27% | 77.10% | 57.44% | -19.53% |
| Efficiency Ratios | |||||
| Receivables Turnover | 15.70 | 17.05 | 16.25 | 12.03 | 16.02 |
| Payables Turnover | 10.34 | 9.33 | 13.41 | 12.16 | 9.30 |
| Inventory Turnover | 12.12 | 12.01 | 17.97 | 15.39 | 10.13 |
| Fixed Asset Turnover | 57.00 | 50.23 | 103.71 | 44.82 | 18.70 |
| Asset Turnover | 0.59 | 0.65 | 0.70 | 0.74 | 0.86 |
| Working Capital Turnover Ratio | 0.89 | 1.04 | 1.29 | 1.61 | 1.64 |
| Cash Conversion Cycle | 18.05 | 12.66 | 15.55 | 24.03 | 19.60 |
| Days of Sales Outstanding | 23.25 | 21.40 | 22.46 | 30.33 | 22.79 |
| Days of Inventory Outstanding | 30.11 | 30.38 | 20.31 | 23.72 | 36.04 |
| Days of Payables Outstanding | 35.32 | 39.12 | 27.22 | 30.02 | 39.23 |
| Operating Cycle | 53.37 | 51.78 | 42.77 | 54.05 | 58.83 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 4.86 | 5.59 | 16.30 | 121.13 | 3.58 |
| Free Cash Flow Per Share | 4.39 | 4.88 | 15.68 | 116.89 | 0.56 |
| Dividend Paid and CapEx Coverage Ratio | 1.17 | 1.37 | 26.44 | 28.61 | 1.18 |
| Capital Expenditure Coverage Ratio | 10.47 | 7.86 | 26.44 | 28.61 | 1.18 |
| Operating Cash Flow Coverage Ratio | 4.39 | 3.93 | 44.59 | 143.21 | 1.12 |
| Operating Cash Flow to Sales Ratio | 0.06 | 0.06 | 0.17 | 1.31 | 0.04 |
| Free Cash Flow Yield | 29.91% | 39.53% | 70.58% | 651.83% | 3.13% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 1.61 | 1.31 | 1.30 | 1.74 | -5.12 |
| Price-to-Sales (P/S) Ratio | 0.19 | 0.14 | 0.23 | 0.19 | 0.20 |
| Price-to-Book (P/B) Ratio | 0.15 | 0.13 | 0.24 | 0.25 | 0.31 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 3.34 | 2.53 | 1.42 | 0.15 | 31.98 |
| Price-to-Operating Cash Flow Ratio | 3.02 | 2.21 | 1.36 | 0.15 | 4.96 |
| Price-to-Earnings Growth (PEG) Ratio | -0.51 | -0.03 | 0.02 | -0.00 | 0.14 |
| Enterprise Value Multiple | -9.03 | -7.88 | -5.68 | -6.94 | 13.20 |
| Enterprise Value | -989.53M | -979.11M | -975.27M | -849.79M | -631.43M |
| EV to EBITDA | -9.03 | -7.88 | -5.68 | -6.94 | 13.20 |
| EV to Sales | -1.23 | -1.06 | -0.96 | -0.86 | -0.67 |
| EV to Free Cash Flow | -21.92 | -19.16 | -5.89 | -0.68 | -106.46 |
| EV to Operating Cash Flow | -19.82 | -16.72 | -5.67 | -0.66 | -16.52 |
| Tangible Book Value Per Share | 95.16 | 90.12 | 88.48 | 69.84 | 54.48 |
| Shareholders’ Equity Per Share | 96.88 | 91.68 | 90.68 | 72.17 | 57.04 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.06 | 0.11 | 0.11 | 0.17 | 0.00 |
| Revenue Per Share | 78.51 | 88.00 | 96.39 | 92.44 | 88.58 |
| Net Income Per Share | 9.28 | 9.41 | 17.13 | 10.30 | -3.47 |
| Tax Burden | 0.94 | 0.89 | 0.89 | 0.83 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.27 | 1.19 | 0.69 |
| Research & Development to Revenue | 0.26 | 0.27 | 0.25 | 0.32 | 0.44 |
| SG&A to Revenue | 0.34 | 0.35 | 0.10 | 0.11 | 0.10 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.09 | 0.02 |
| Income Quality | 0.52 | 0.59 | 0.95 | 1.72 | -1.03 |
Currency in CNY
